How to treat hypertension in diabetic patients

References

• Working Group on Hypertension In Diabetes. Statement on hypertension In diabetes mellitus: final report. Arch Intern Med 1987: 147(5): 830–42
   PubMedGoogle Scholar
• Kannel WB. Hypertension: relationship with other risk factors. Drugs 1986: 31 (Suppl 1): 1–11
   PubMed Web of Science ®Google Scholar
• Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease: new perspectives based on the Framingham Study. Ann Intern Med 1979: 90(1): 85–91
   PubMed Web of Science ®Google Scholar
• Rosenstock J, Raskin P. Early diabetic nephropathy: assessment and potential therapeutic Interventions. Diabetes Care 1986: 9(5): 529–45
   PubMed Web of Science ®Google Scholar
• Unger RH, Foster DW. Diabetes mellitus. In: Wilson JD. Foster DW. eds. Williams textbook of endocrinology. 7th ed. Philadelphia: WB Saunders. 1985: 1018–80
   Google Scholar
• Mogensen CE, Christensen CK. Predicting diabetic nephropathy In Insulin-dependent patients. N Engl J Med 1984: 311(2): 89–93
   PubMed Web of Science ®Google Scholar
• Parving HH, Oxenboll B, Svendsen PA, et al. Early detection of patients at risk of developing diabetic nephropathy: a longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) 1982: 100(4): 550–5
   Google Scholar
• Mathiesen ER. Ozenboll B, Johansen K. et al. Incipient nephropathy In Type 1 (Insulin-dependent) diabetes. Diabetologia 1984: 26(6): 406–10
   PubMed Web of Science ®Google Scholar
• Viberti GC. Hill RD, Jarrett RJ, et al. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982: 1(8287): 1430–2
   PubMed Web of Science ®Google Scholar
• Parving HH, Andersen AR, Smldt UM. et al. Effect of antihypertensive treatment on kidney function In diabetic nephropathy. Br Med J (Clin Res) 1987: 294(6585): 1443–7
   PubMed Web of Science ®Google Scholar
• Prichard BN. Hypertension: current therapeutic practice reviewed. Drugs 1986: 31 (Suppl 1): 67–70
   PubMed Web of Science ®Google Scholar
• Taylor SH. Chairman's summary. Drugs 1986: 31 (Suppl 1): 71–3
   Web of Science ®Google Scholar
• Kaplan NM, Rosenstock J, Raskin P. A differing view of treatment of hypertension In patients with diabetes mellitus. Arch Intern Med 1987: 147(6): 1160–2
   PubMedGoogle Scholar
• Webster J, Newnham D, Robb OJ, et al. Antihypertensive effect of single doses of enalapril in hypertensive patients treated with bendrofluazlde. Br J Clin Pharmacol 1987: 23(2): 151–7
   PubMed Web of Science ®Google Scholar
• Bengtsson C, Blohme G, Lapidns L, et al. Do antihypertensive drugs precipitate diabetes? Br Med J (Clin Res) 1984: 289(6457): 1495–7
   PubMedGoogle Scholar
• Dornhorst A. Powell SH, Pensky J. Aggravation by propranolol of hyperglycaemic effect of hydrochlorothiazide in type II diabetics without alteration of insulin secretion. Lancet 1985: 1 (8421): 123–6
   PubMed Web of Science ®Google Scholar
• Weinberger MH. Influence of an angiotensin converting-enzyme inhibitor on diuretic-induced metabolic effects in hypertension. Hypertension 1983: 5(5 Pt 2): III 132–8
   Google Scholar
• Croog SH, Levine S, Testa MA. et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986: 314(26): 1657–64
   PubMed Web of Science ®Google Scholar
• Schoenfeld MR, Goldberger E. Hypercholesterolemia Induced by thiazides: a pilot study. Curr Ther Res 1964: 6: 180–4
   PubMed Web of Science ®Google Scholar
• Ames RP. Coronary heart disease and the treatment of hypertension: Impact of diuretics on serum Uplds and glucose. J Cardiovasc Pharmacol 1984: 6(Suppl 3): 466–S73
   Google Scholar
• Struthers AD. Murphy MB, Dollery CT. Glucose tolerance during antihypertensive therapy in patients with diabetes mellitus. Hypertension 1985: 7(6 Pt 2): 1195–101
   Google Scholar
• Shionoiri H. Noda K, Miyamoto K, et al. Glucose tolerance during chronic prazosin therapy in patients with essential hypertension. Curr Ther Res 1986: 40: 171–80
   Web of Science ®Google Scholar
• Bhatnagar SK. Amin MM. AI-Yusuf AR. Diabetogenic effects of nifedipine. Br Med J (Clin Res) 1984 289(6436): 19
   PubMedGoogle Scholar
• Persha dsingh HA. Grant N, McDonald JM. Association of diltiazem therapy with Increased Insulin resistance In a patient with Type I diabetes mellitus. (Letter) JAMA 1987: 257(7): 930–1
   Web of Science ®Google Scholar
• Banas JS. ACE Inhibition: a comparison of Captopril and enalapril. Today's Ther Trends 1987: 15–26
   Google Scholar
• Weber MA, Zusman RM. ACE Inhibitors In hypertension. Drug Therapy 1986: 16: 43–54
   Google Scholar
• Weinberger MH. Comparison of Captopril and hydrochlorothiazide alone and in combination in mild to moderate essential hypertension. Br J Pharmacol 1982: 14: 127–31S
   Google Scholar
• Carey M, Blake S. Comparative efficacy of Captopril and atenolol in moderately severe essential hypertension. Postgrad Med J 1986: 62(Suppl 1): 111–2
   PubMedGoogle Scholar
• Garanin G. A comparison of once dally antihypertensive therapy with Captopril and enalapril. Curr Ther Res 1986: 40: 567–75
   Web of Science ®Google Scholar
• D'Angelo A, Sartori L, Gambaro G, et al. Captopril in the treatment of hypertension in type I and type II diabetic patients. Postgrad Med J 1986: 62(Suppl 1): 69–72
   PubMedGoogle Scholar
• Dominguez JR, de la Galle H, Hurtado A, et al. Effect of converting enzyme inhibitors in hypertensive patients with non-insulin dependent diabetes mellitus. Postgrad Med J 1986: 62(Suppl 1): 66–8
   PubMedGoogle Scholar
• Matthews DM. Wathen CG. Bell D, et al. The effect of Captopril on blood pressure and glucose tolerance in hypertensive non-insulin dependent diabetics. Postgrad Med J 1986: 62(Suppl 1): 73–5
   PubMedGoogle Scholar
• Groel JT, Tadros SS, Dreslinskl GR. et al. Long-term antihypertensive therapy with Captopril. Hypertension 1983: 5(5 Pt 2): III 145–51
   Google Scholar
• Ferriere M, Lachkar H, Richard JL, et al. Captopril and insulin sensitivity. (Letter) Ann Intern Med 1985: 102(1): 134–5
   PubMed Web of Science ®Google Scholar
• McMurray J, Fraser DM. Captopril, enalapril and blood glucose. (Letter) Lancet 1986: 1(8488): 1035
   PubMed Web of Science ®Google Scholar
• Passa P, Marre M, Ieblanc H. Enalapril, captopril, and blood glucose. (Letter) Lancet 1986: 1 (8495): 1447
   PubMed Web of Science ®Google Scholar
• Winocour P, Waldek S, Anderson DC. Captopril and blood glucose. (Letter) Lancet 1986: 2(8504): 461
   PubMed Web of Science ®Google Scholar
• Tagnma Y, Kitamoto T, Futaki G, et al. Effect of Captopril on heavy proteinuria in azotemic diabetes. N Engl J Med 1985: 313(26): 1617–20
   PubMed Web of Science ®Google Scholar
• Hommel E. Parving HH, Mathiesen E. et al. Effect of Captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J (Clin Res) 1986: 293(6545): 467–70
   PubMed Web of Science ®Google Scholar
• Bjorck S, Nyberg G. Mulec H, et al. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J (Clin Res) 1986: 293(6545): 471–4
   PubMed Web of Science ®Google Scholar
• Marre M, LeBlanc H, Suarez L, et al. Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. Br Med J (Clin Res) 1987: 294(6585): 1448–52
   PubMed Web of Science ®Google Scholar